SCHEMBL20248909

SCHEMBL20248909

N#Cc1cc(C#N)cc(-c2cc3c(-c4ccccc4)c4sccc4c(-c4ccccc4)c3s2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.34
▸ CYP1A1 P04798 1/20 0.33
▸ CYP1B1 Q16678 1/20 0.33
▸ FASN P49327 2/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ XDH P47989 2/20 0.32
▸ SLC22A12 Q96S37 2/20 0.32
▸ PTP4A3 O75365 1/20 0.32
▸ PTP4A2 Q12974 1/20 0.32
▸ PTP4A1 Q93096 1/20 0.32
▸ PDE2A O00408 1/20 0.31
▸ CHEK1 O14757 1/20 0.31
▸ HPGDS O60760 1/20 0.31
▸ ADORA2A P29274 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20254282 0.94 XDH (0.32) METAP2CYP1A1CYP1B1FASNMEN1
SCHEMBL20254262 0.93 HPGDS (0.33) METAP2CYP1A1CYP1B1FASNMEN1
SCHEMBL20254266 0.90 CYP1A1 (0.38) METAP2CYP1A1CYP1B1FASNMEN1
SCHEMBL20254263 0.82 HPGDS (0.37) METAP2CYP1A1CYP1B1FASNMEN1
SCHEMBL28855928 0.82 ADORA2A (0.39) METAP2MEN1KMT2AADORA2AUSP2
SCHEMBL20248875 0.81 ADORA2A (0.43) CYP1A1CYP1B1MEN1KMT2AADORA2A
SCHEMBL20248872 0.78 ADORA2A (0.46) CYP1A1CYP1B1MEN1KMT2APTP4A3
SCHEMBL20254261 0.78 ADORA2A (0.43) MEN1KMT2AADORA2AUSP2LMNA
SCHEMBL20254260 0.78 KAT6A (0.37) PTP4A3PTP4A2PTP4A1
SCHEMBL20248873 0.77 ADORA2A (0.45) CYP1A1CYP1B1MEN1KMT2APTP4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10347846-B2 Organic compound for organic EL device and using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-07-09 — — US disclosed
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-06-14 — — US disclosed
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10347846-B2 Organic compound for organic EL device and using the same L1CAM, ESR1, XPO4 METAP2 3470/4885CYP1A1 123/4885CYP1B1 433/4885
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME L1CAM, ESR1, XPO4 METAP2 3470/4885CYP1A1 123/4885CYP1B1 433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback